Ergopeptine-sensitive calcium-dependent protein phosphorylation system in the brain

Area of Science:

• Neuroscience
• Molecular Biology
• Pharmacology

Background:

• Protein phosphorylation is a key regulatory mechanism in cellular signaling.
• Dopamine-mimetic ergot compounds, like bromocriptine, exert significant effects on the central nervous system (CNS).
• Calcium and calmodulin are crucial regulators of many cellular processes, including protein phosphorylation.

Purpose of the Study:

• To investigate the effect of bromocriptine on protein phosphorylation in a synaptosome fraction.
• To identify the specific proteins and phosphorylation sites affected by bromocriptine.
• To explore the potential mechanism underlying bromocriptine's CNS activity.

Main Methods:

• Studied endogenous protein phosphorylation in brain synaptosomes.
• Utilized bromocriptine and related compounds to assess inhibitory effects.
• Examined the influence of calcium and calmodulin on phosphorylation.
• Investigated regional distribution of affected proteins in the brain.

Main Results:

• Bromocriptine selectively inhibited threonine phosphorylation of 50,000- and 60,000-dalton proteins.
• This phosphorylation is stimulated by calcium and calmodulin and occurs mainly in the brain.
• Other ergots with peptide moieties mimicked bromocriptine's inhibitory effect, but dopamine or neurotransmitters did not.
• Affected proteins were highly concentrated in the hippocampus, potentially localized to interneurons.

Conclusions:

• Bromocriptine's inhibition of calcium/calmodulin-dependent protein phosphorylation may mediate its CNS effects.
• Specific protein targets of bromocriptine in the CNS were identified.
• The findings suggest a novel mechanism for ergot compound action in the brain.